TY - JOUR
T1 - An assessment of readiness for behaviour change in patients prescribed ocular hypotensive therapy
AU - Schwartz, G. F.
AU - Plake, K. S.
AU - Mychaskiw, M. A.
N1 - Funding Information:
The editorial support, including contributing to the first draft of the manuscript, revising the paper based on author feedback, and styling the paper for journal submission was provided by Jane G Murphy, PhD, of Zola Associates and was funded by Pfizer Inc., New York, NY, USA. Drs Schwartz and Plake were paid consultants to Pfizer in connection with the development of this study. Dr Mychaskiw is an employee of Pfizer Inc.
PY - 2009/8
Y1 - 2009/8
N2 - Objectives: To compare responses in two patient populations with a questionnaire developed to identify those prescribed ocular hypotensive medication whose adherence may need improvement and who may be ready to change. Methods: The content/face validity of a 62-item, self-administered questionnaire was confirmed by nine glaucoma specialists. Questions concerned demographics, health and medications, use of/problems with medications, and visual function. The questionnaire was administered anonymously to 102 consecutive patients in a glaucoma referral practice ('glaucoma practice') and 100 from a multispecialty ophthalmology practice ('multispecialty practice'). All participants were prescribed ≥1 ocular hypotensive medication and had no previous trabeculectomy. Results: Patients in the glaucoma practice were more likely to be younger, African-American, and better educated (P<0.05 for each). In both, >80% had glaucoma with >60% diagnosed ≥3 years previously. Most (glaucoma, multispecialty: 87, 93%) reported administering drops every day, but more in the multispecialty practice reported administering drops at the same time every day (79, 92%; P<0.05). Number of adherence problems (mean, 1/patient) and adherence scores (mean, 24; possible scale range, 0-25) were similar. Common adherence barriers were falling asleep and forgetting when the regular schedule changed or when travelling. In the glaucoma practice, the number of adherence problems was correlated with adherence score (r=-0.611; P<0.0001) and number of side effects (r=0.349; P<0.0001). Conclusions: Similarities between patient populations limited our ability to compare responses between groups or to propose adherence counselling tailored to specific demographics. Until such recommendations are possible, physicians should incorporate adherence counselling broadly into their practices.
AB - Objectives: To compare responses in two patient populations with a questionnaire developed to identify those prescribed ocular hypotensive medication whose adherence may need improvement and who may be ready to change. Methods: The content/face validity of a 62-item, self-administered questionnaire was confirmed by nine glaucoma specialists. Questions concerned demographics, health and medications, use of/problems with medications, and visual function. The questionnaire was administered anonymously to 102 consecutive patients in a glaucoma referral practice ('glaucoma practice') and 100 from a multispecialty ophthalmology practice ('multispecialty practice'). All participants were prescribed ≥1 ocular hypotensive medication and had no previous trabeculectomy. Results: Patients in the glaucoma practice were more likely to be younger, African-American, and better educated (P<0.05 for each). In both, >80% had glaucoma with >60% diagnosed ≥3 years previously. Most (glaucoma, multispecialty: 87, 93%) reported administering drops every day, but more in the multispecialty practice reported administering drops at the same time every day (79, 92%; P<0.05). Number of adherence problems (mean, 1/patient) and adherence scores (mean, 24; possible scale range, 0-25) were similar. Common adherence barriers were falling asleep and forgetting when the regular schedule changed or when travelling. In the glaucoma practice, the number of adherence problems was correlated with adherence score (r=-0.611; P<0.0001) and number of side effects (r=0.349; P<0.0001). Conclusions: Similarities between patient populations limited our ability to compare responses between groups or to propose adherence counselling tailored to specific demographics. Until such recommendations are possible, physicians should incorporate adherence counselling broadly into their practices.
KW - Adherence
KW - Compliance
KW - Glaucoma
KW - Ocular hypotensive medication
UR - http://www.scopus.com/inward/record.url?scp=69049083739&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=69049083739&partnerID=8YFLogxK
U2 - 10.1038/eye.2008.337
DO - 10.1038/eye.2008.337
M3 - Article
C2 - 19011605
AN - SCOPUS:69049083739
SN - 0950-222X
VL - 23
SP - 1668
EP - 1674
JO - Eye
JF - Eye
IS - 8
ER -